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ras proteins induce germinal vesicle breakdown (GVBD) when microinjected into Xenopus laevis oocytes. The mechanism of action is still 
unresolved, although several hypotheses have been proposed. Acylphosphatase is a cytosolic enzyme that specifically catalyses the hydrolysis of 
the carboxylphosphate bond of acylphosphate for the removal of acylphosphate r sidues of various membrane pumps. A direct effect of 
acylphosphatase on the regulation of ionic balance of a cell by interaction with ionic membrane pumps has been proposed. We have analyzed the 
effect of microinjecting acylphosphatase, by itself or along with ras-p21 proteins or progesterone, into oocytes. The enzyme alone is unable to induce 
GVBD, but increases oocyte maturation induced by progesterone. By contrast, acylphosphatase blocked GVBD induced by microinjection of 
oncogenic ras-p21. These data suggest hat acylphosphatase acts synergistically or antagonistically with factors involved in proliferating signals 
by altering the intracellular ionic conditions of the cell, conforming the hypothesis that the intracellular ionic condition of the cell is important 
in the induction of proliferating signals, and that its perturbation may have a serious effect on signal transduction. 
ras; Acylphosphatase; Progesterone; Xenopus laevis oocyte 
1. INTRODUCTION 
Acylphosphatase (EC 3.6.1.7) is a cytosolic enzyme 
catalysing the hydrolysis of organic acylphosphates [1]. 
It is present in mammalian tissues in two isoforms, mus- 
cular and erythrocytic [2]. The structural and functional 
properties of acylphosphatases purified from skeletal 
muscle of various vertebrate species have been investi- 
gated [3-5]; they all share similar kinetic properties and 
a highly conserved primary structure [5]. 
The biological function of acylphosphatase i  still un- 
resolved. Several studies have shown that it is able to 
hydrolyse the phosphoenzyme intermediate of various 
membrane pumps, such as Na+/K+-ATPase, Ca2+/ 
Mg2+-ATPase and Ca2+-ATPase [6-9]. This effect is me- 
diated by dephosphorylation of an aspartate residue [10] 
that belongs to the highly conserved sequence, CSDK, 
found in several ATPases of the family of the ELE2-type 
of transport ATPases. This sequence seems to be the 
target for the phosphorylation~zlephosphorylation 
mechanism of such membrane proteins resulting in the 
modulation of the ionic homeostasis of the cell. 
Xenopus laevis oocytes represent a population of cells 
blocked in the G JM phase of the first meiotic division 
[11]. Various effectors, either hormonal, such as proges- 
terone and insulin, or not, such as TPA or activated 
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ras-p21 [12], can release this block by different mecha- 
nisms, inducing germinal vesicle breakdown (GVBD), 
a process imilar to mitogenic induction of mammalian 
cells. In keeping with the analogy between oocytes and 
mammalian cells, microinjection of oncogenic ras-p21 
proteins into fibroblasts induce synthesis of DNA [13]. 
This process seems to be related to the activation of 
tyrosine kinase receptors by growth factors, such as 
platelet-derived growth factor (PDGF) and insulin [14]. 
ras-p21 proteins belong to the superfamily of small 
GTPases that play a critical role in signal transduction 
of multiple cellular functions [15], among them the reg- 
ulation of proliferation and differentiation, ras protein 
also play an important role in the generation of a large 
variety of tumors in animals and humans [16]. In spite 
of the fact that ras proteins have been largely investi- 
gated, elucidation of their mechanism of action still re- 
mains elusive. The possible regulatory effect of ras pro- 
teins on K ÷ channels [17] and intracellular pH [18] has 
been described in mammalian cells. Since acyl- 
phosphatase may regulate some of the structural ele- 
ments of ionic fluxes, we have investigated the effect of 
microinjection of acylphosphatase into the X. laevis 
oocyte system. Specifically we have injected purified 
active rat skeletal muscle acylphosphatase into oocytes 
stimulated by either ras-p21 or progesterone. Our re- 
sults indicate that acylphosphatase specifically antago- 
nizes the biological function of ras proteins, but in- 
creases progesterone-induced GVBD, a recognized in- 
dependent mitogenic signalling pathway in oocytes. 
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2. MATERIALS  AND METHODS 
2.1. Oocytes preparation and microinjection 
Stage VI oocytes were obtained and microinjected as previously 
described [19]. Oocytes were maintained inRinger's buffer (NaC1100 
raM, KC1 1.8 mM, MgCI2 2 mM, CaC12 1 mM, NaHCO3 4 mM, pH 
7.8) [19]. Groups of 2~30 oocytes were microinjected with indicated 
amounts of BSA, acylphosphatase or ras-p21 proteins in a final vol- 
ume of 50 nl 20 mM MES, pH 7.0. 
2.2. Protein purification 
Rat skeletal muscle acylphosphatase was isolated according to 
Ramponi et al. [20]. Recombinant activated ras-p21 was isolated as 
previously described [19]. Both proteins were resuspended in 20 mM 
MES, pH 7.0. 
2.3. Maturation assay 
Oocytes were incubated after microinjection for different imes at 
room temperature in Ringer's buffer supplemented with indicated 
amounts of progesterone. Oocytes were fixed in 10% trichloroacetic 
acid (TCA) and monitored by dissection for the disappearance of the 
germinal vesicle (GVBD) under a Zeiss stereomicroscope GSZ. 
2.4. Ao'lphosphatase ctivity assay 
Oocytes were either injected with 10 ng of acylphosphatase or with 
10 ng of BSA, both being dissolved in 20 mM MES, pH 7.0. At 
indicated times after microinjection, different sets of oocytes were 
treated by the acetone powder method [21]. The powder obtained was 
finally dissolved in ice-cold 0.1 M sodium acetate, pH 5.3, and centri- 
fuged. Acylphosphatase ctivity was analyzed in the supernatants with 
5 mM benzoylphosphate as substrate [22]. 
3. RESULTS AND DISCUSSION 
3.1. Stability of injected acylphosphatase after microin- 
jection 
The soluble fraction of  X. laevis oocytes was obtained 
by the acetone powder method (see section 2). As previ- 
ously reported [1], due to its structural properties, the 
acylphosphatase enzyme conserves its activity after pu- 
rif ication by this method providing a rapid method for 
detection and analysis of  acylphosphatase activity in X. 
laevis oocytes using the benzoylphosphate assay [22]. 
Both acylphosphatase and control,  BSA-injected 
oocytes were tested. As shown in Fig. 1, the oocytes 
injected with active enzyme showed about  250-times 
more activity than control,  BSA-injected oocytes at 10 
min or 18 h after injection. The homogenates assayed 
at longer times after microinjection showed a slight de- 
crease in acylphosphatase activity compared to the 
oocytes injected and processed at 10 min. The decrease 
in activity was less than 20% of the total, demonstrat ing 
that injected acylphosphatase r mains stable and enzy- 
matical ly active for several hours after injection, suffi- 
cient to ascertain its biological activity in the X. laevis 
oocyte system. 
3.2. Biological effect of acylphosphatase injection 
We then investigated whether acylphosphatase by it- 
self was able to part ic ipate in signal transduct ion proc- 
esses by inducing GVBD when microinjected into the 
oocytes. Different amounts of  either acylphosphatase or 
Table I 
Effect of microinjection of acylphosphatase into X. laevis oocytes 
Microinjection % GVBD 
(ng/oocyte) 
Control* 
BSA 
Acylphosphatase 
ras-p21 
10+2 
10 14 + 3 
170 14 + 3 
10 16 _+ 1 
170 14 + 3 
30 95 + 5 
Oocytes were selected and microinjected with the indicated proteins 
in 50 nl of 20 mM Mes, pH 7.0, as described in section 2. GVBD was 
analyzed 20 h after injections as described. 
*Not microinjected. 
BSA were injected, and the disappearance of the germi- 
nal vesicle analyzed by split-open, TCA-f ixed oocytes 
after 20 h of  incubation in Ringer's buffer. As shown in 
Table I, no increase in the GVBD rates was detected in 
acylphosphatase- injected oocytes compared to the con- 
trol, BSA-injected oocytes. These results suggest that 
acylphosphatase does not play a significant role in the 
induction of  GVBD by itself; however, the putative im- 
pl ication of  acylphosphatase in the regulation of  ionic 
cellular balance, part icular ly on Ca 2+ homeostasis,  has 
been investigated, indicating that acylphosphatase af- 
fects Ca 2+ entry into the oocytes by inhibit ing the func- 
tion of  the ionic machinery [23]. Thus, acylphosphatase 
could either enhance or interfere with the signall ing 
process of  other wel l -known init iators of  oocyte matu- 
ration. 
3.3. Effects of acylphosphatase injection on ras-p21 and 
progesterone-induced GVBD 
It has been reported that injection of  ras-p21 protein 
into X. laevis oocytes is able to induce GVBD [12]. The 
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Fig. I. Acylphosphatase ctivity assay. Activity of homogenates from 
oocytes previously injected with either 10 ng/oocyte BSA or 10 ng/ 
oocyte acylphosphatase. The assays were carried out by incubating the 
oocyte homogenates for 30 rain in 5 mM benzoylphosphate as sub- 
strate. Each point, consisting of sets of 5 oocytes, was normalized to 
10 pg of protein. The results are expressed as times of activity of 
homogenates above the spontaneous hydrolysis of ben- 
zoylphosphatate as control ([]) BSA-injected oocytes. (m) Acyl- 
phosphatase-injected oocytes. 
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Fig. 2. Effect of acylphosphatase on GVBD induced by ras-p21. 
Oocytes were microinjected with the indicated amounts of ras-p21 plus 
BSA (m) or plus acylphosphatase ([]), and analyzed after 20 h of 
incubation in Ringer's buffer at room temperature. 
mechanism of action of ras oncogene in X. laevis 
oocytes is still unclear, however as oncogene pathways 
have been widely investigated in eukaryotic ell systems. 
Thus, it has been suggested that ionic fluxes may some- 
how be regulated by ras protein through its GTPase- 
activating protein, GAP-ras [24]. Particularly a rise of 
intracellular pH can be observed after microinjection of 
activated ras protein [18], and a decrease of K + fluxes 
through the plasma membrane can be observed in cells 
injected with ras-p21 [17]. 
A dose-response curve was performed using a ras- 
p21 protein constitutively activated by two point muta- 
tions at Va112 and Thr 59 [25] to calculate the concentra- 
tion of protein injected required to obtain semi-maximal 
rates of GVBD (GVBDs0) at 20 h of incubation. 5 ng/ 
oocyte of the ras oncoprotein was found to give a 
GVBDs0 at the indicated time point (data not shown). 
Thus, we microinjected 5 ng/oocyte of ras-p21 along 
with 85 ng/oocyte of purified rat skeletal muscle acyl- 
phosphatase in a final volume of 50 nl/oocyte. As shown 
in Fig. 2, ras-induced GVBD was totally abolished by 
acylphosphatase. To investigate further if the blocking 
action of acylphosphatase was due to a specific or non- 
100 
specific effect of the enzyme in the X. laevis oocyte 
system, we performed a control experiment using pro- 
gesterone to induce GVBD. 
For comparison with the results obtained by co-injec- 
tion of ras-p21 and acylphosphatase, a dose response 
curve was carried out with progesterone to obtain the 
GVBDs0. The optimal dose for a GVBDs0 at 20 h of 
incubation was found to be 0.5 flg/ml (data not shown). 
When the same amount of acylphosphatase as used with 
the ras-p21 protein was injected in 50 nl/oocyte, and the 
oocytes were treated with 0.5 pg/ml of progesterone, an 
increase in GVBD by acylphosphatase microinjection 
was observed (Fig. 3). The effect of progesterone treat- 
ment on X. laevis oocytes has been widely investigated 
[11,26,27], but nevertheless the mechanism of action of 
this hormone in X. laevis oocytes is still not fully under- 
stood. It is accepted, however, that progesterone-in- 
duced GVBD follows a different pattern from that in- 
duced by ras-p21 [28]. These results suggest hat acyl- 
phosphatase action on ras-induced GVBD is not due to 
non-specific blockage of cellular metabolism. 
In this study we have carried out microinjection ex- 
periments in X. laevis oocytes to study the effects of 
acylphosphatase on ras-induced GVBD. Previous re- 
ports have suggested that acylphosphatase may affect 
the regulation of ionic homeostasis of the cell by con- 
trolling membrane ATPases [6-9]. We show that this 
enzyme may act on intracellular signalling pathways 
with different results, since acylphosphatase blocked 
ras-induced GVBD but increased that induced by pro- 
gesterone. Thus, our results suggest an important role 
for acylphosphatase on the regulation of cell signalling. 
As previously described, ionic homeostasis of the cell 
could cooperate in the biological function of ras pro- 
teins, particularly the regulation of intracellular pH [18] 
and K + fluxes [17]. Our results strongly support this 
hypothesis by using an enzyme involved in the regula- 
tion of ionic fluxes. Further research using this system 
will be useful for a better understanding of the involve- 
ment of membrane pumps in the biological function of 
ras proteins both in the oocyte system and in mamma- 
lian cells. 
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Fig. 3. Effect of acylphosphatase on progesterone-induced GVBD. 
Oocytes were microinjected with the indicated amounts of BSA (m) or 
acylphosphatase ([]), and then treated with 0.5 pg/ml progesterone. 
The rate of GVBD was observed after 20 h incubation in Ringer's 
buffer. 
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